F-18-FDG PET/CT imaging evaluating the effect of metformin on myocardial ischemia/reperfusion injury in rats

Hang Su,Yi Tian,Ying Zhang,Tiantian Mou,Xiaofen Xie,Ziwei Zhu,Xiang Li,Marcus Hacker,Xiaoli Zhang
DOI: https://doi.org/10.3969/j.issn.1007-5062.2018.12.021
2018-01-01
Journal of Nuclear Medicine
Abstract:368 Objectives: To dynamically evaluate the effect of metformin (MF) in a rat model of ischemia/reperfusion (I/R) injury at different time points by 18F-fluorodeoxyglucose (18F-FDG) micro PET/CT imaging. Methods: The I/R injury model in Sprague-Dawley (SD) rat was established by ligation of left anterior descending (LAD) coronary artery near the pulmonary arch root for 30min. SD rats (n=12) were randomly divided into 2 groups: control group (n=6) without any intervention and metformin intervention (MF) group (n=6) with oral administration of metformin (50 mg/kg) twice per day. Rats were anesthetized with isoflurane. Gated 18F-FDG(40Mbq)micro PET/CT imaging was performed at different time points (day 1st , day 7th , day 14th and day 30th after surgery) for 10min. Volumes of interest (VOIs) were drawn to identify different myocardium regions (ischemia center, peri-ischemia area and remote area). Standardized uptake values (SUVs) (SUVmean and SUVmax) were analyzed to evaluate the FDG uptake activity, and center/remote ratio was calculated. In addition, the left ventricular (LV) end-diastolic volume (EDV), end-systolic volume (ESV) and LV ejection fraction (LVEF) were obtained. 30th day at the end of study, the rats were scarified and myocardial ischemia was analyzed by TTC (2,3,5-triphenyl-tetrazolium chloride) staining and demonstrated by pathology. Results: In control group, center/remote ratio was gradually reduced from 1st day to 30th day after reperfusion. In the meantime, LVEDV was increased gradually with time. And there was a significant negative correlation between center/remote ratio and LVEDV (r = -0.732,p 0.05). At day 30th after reperfusion, center/remote ratio in MF group was significantly higher than that in control group (0.81±0.06 vs 0.65±0.09, p 0.05). Conclusions: MF attenuated the severity of I/R injury on myocardium and thus, may delay or prevent the progress of LV remodeling. It warrants further investigation to evaluate the effects of I/R injury on the myocardium with different dose of MF treatment. Keywords: ischemia/reperfusion injury; metformin; PET/CT; 18F-FDGFund project: National Natural Science Fund (NO.81071177, 81571717)
What problem does this paper attempt to address?